Literature DB >> 16640956

Genetic susceptibility to thrombosis.

James P Luyendyk1, Rachel E Tilley, Nigel Mackman.   

Abstract

Thrombosis is associated with atherosclerosis, sepsis, cancer, and numerous other inflammatory diseases. Complications of thrombosis, such as myocardial infarction, stroke, and venous thromboembolism, contribute significantly to morbidity and mortality. Susceptibility to thrombosis is conferred by both genetic and environmental factors. Tissue factor is the primary cellular initiator of blood coagulation and is a major contributor to thrombosis. In this review, we discuss the association between various polymorphisms and the risk for thrombosis.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16640956     DOI： 10.1007/s11883-006-0073-1

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN： 1523-3804            Impact factor:   5.113


  45 in total

1.  Soluble P-selectin levels, P-selectin polymorphisms and cardiovascular disease.

Authors:  A M Carter; K Anagnostopoulou; M W Mansfield; P J Grant
Journal:  J Thromb Haemost       Date:  2003-08       Impact factor: 5.824

Review 2.  Thrombus formation in vivo.

Authors:  Bruce Furie; Barbara C Furie
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

3.  P-selectin induces the expression of tissue factor on monocytes.

Authors:  A Celi; G Pellegrini; R Lorenzet; A De Blasi; N Ready; B C Furie; B Furie
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

4.  Tissue factor pathway inhibitor and the risk of recurrent venous thromboembolism.

Authors:  Matthias Hoke; Paul A Kyrle; Erich Minar; Christine Bialonzcyk; Mirko Hirschl; Barbara Schneider; Marietta Kollars; Ansgar Weltermann; Sabine Eichinger
Journal:  Thromb Haemost       Date:  2005-10       Impact factor: 5.249

5.  Interaction between the C-260T polymorphism of the CD14 gene and the plasma IL-6 concentration on the risk of myocardial infarction: the HIFMECH study.

Authors:  P E Morange; N Saut; M C Alessi; C Frere; E Hawe; J S Yudkin; E Tremoli; M Margaglione; G Di Minno; A Hamsten; S E Humphries; I Juhan-Vague
Journal:  Atherosclerosis       Date:  2004-12-24       Impact factor: 5.162

6.  Porphyromonas gingivalis bacteremia induces coronary and aortic atherosclerosis in normocholesterolemic and hypercholesterolemic pigs.

Authors:  Nadine Brodala; Elizabeth P Merricks; Dwight A Bellinger; Damrong Damrongsri; Steven Offenbacher; James Beck; Phoebus Madianos; Daniela Sotres; Yu-Ling Chang; Gary Koch; Timothy C Nichols
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-04-21       Impact factor: 8.311

7.  Absence of P-selectin delays fatty streak formation in mice.

Authors:  R C Johnson; S M Chapman; Z M Dong; J M Ordovas; T N Mayadas; J Herz; R O Hynes; E J Schaefer; D D Wagner
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

Review 8.  Haemostatic genetic risk factors in arterial thrombosis.

Authors:  R E Simmonds; J Hermida; S M Rezende; D A Lane
Journal:  Thromb Haemost       Date:  2001-07       Impact factor: 5.249

9.  P-selectin Thr715Pro polymorphism predicts P-selectin levels but not risk of incident coronary heart disease or ischemic stroke in a cohort of 14595 participants: the Atherosclerosis Risk in Communities Study.

Authors:  Kelly A Volcik; Christie M Ballantyne; Josef Coresh; Aaron R Folsom; Kenneth K Wu; Eric Boerwinkle
Journal:  Atherosclerosis       Date:  2005-08-25       Impact factor: 5.162

10.  Short alleles of P-selectin glycoprotein ligand-1 protect against premature myocardial infarction.

Authors:  Vanessa Roldán; Rocío González-Conejero; Francisco Marín; Javier Pineda; Vicente Vicente; Javier Corral
Journal:  Am Heart J       Date:  2004-10       Impact factor: 4.749
View more
  2 in total

1.  Investigation on genetic thrombophilic factors in FFPE autopsy tissue from subjects who died from pulmonary embolism.

Authors:  Francesco Brandimarti; Federica Alessandrini; Mauro Pesaresi; Chiara Catalani; Letizia De Angelis; Roberta Galeazzi; Simona Giovagnetti; Rosaria Gesuita; Elisa Righi; Raffaele Giorgetti; Adriano Tagliabracci
Journal:  Int J Legal Med       Date:  2016-12-09       Impact factor: 2.686

2.  Murine strain differences in hemostasis and thrombosis and tissue factor pathway inhibitor.

Authors:  Thomas A White; Shuchong Pan; Tyra A Witt; Robert D Simari
Journal:  Thromb Res       Date:  2009-04-26       Impact factor: 3.944
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.